Related Experiment Videos
Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children
E Yilmaz1, Y Doşan, M K Gürgöze
1Firat University Faculty of Medicine, Elaziş, Turkey. erdmelhan@hotmail.com
Insights
Children on carbamazepine and phenobarbital showed increased serum lipid levels, including cholesterol and triglycerides, after treatment for seizures. Valproic acid did not affect lipid profiles, suggesting careful monitoring for children on enzyme-inducing antiepileptic drugs.
Area of Science:
- Pediatric Neurology
- Clinical Pharmacology
- Biochemistry
Background:
- Epilepsy is a common neurological disorder in children.
- Antiepileptic drugs (AEDs) are the primary treatment for seizures.
- Some AEDs are known to affect lipid metabolism.
Purpose of the Study:
- To investigate the impact of phenobarbital, carbamazepine, and valproic acid on serum lipid profiles in children with newly diagnosed epilepsy.
- To compare the effects of these three commonly prescribed AEDs on lipid parameters.
Main Methods:
- Prospective study involving 53 children with newly diagnosed seizure disorders.
- Serum lipid profiles (total cholesterol, HDL-C, LDL-C, triglycerides) were measured at baseline and after 3 months and 1 year of treatment.
- Patients received either phenobarbital (n=14), carbamazepine (n=21), or valproic acid (n=18).
Main Results:
- Carbamazepine and phenobarbital treatments led to significant increases in serum total cholesterol, HDL-C, LDL-C, and triglycerides after 3 months, which persisted at 1 year.
- Valproic acid therapy did not result in significant changes in any measured serum lipid parameters.
- Elevated lipid levels were observed in children treated with enzyme-inducing AEDs.
Conclusions:
- Phenobarbital and carbamazepine significantly alter serum lipid profiles in children with epilepsy.
- Valproic acid appears to have a neutral effect on serum lipids in this pediatric population.
- Routine monitoring of serum lipid profiles is recommended for children receiving enzyme-inducing AEDs like phenobarbital and carbamazepine.
Abstract:
Serum lipid profile changes were investigated in 53 children receiving phenobarbital (n = 14), carbamazepine (n = 21), and valproic acid (n = 18) for their newly diagnosed seizure disorder. The patients were followed prospectively. Serum total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglyceride concentrations increased after 3 months of treatment with carbamazepine and remained high after one year. Serum total cholesterol levels increased after 3 months of treatment with phenobarbital and remained high after one year. Serum lipid concentrations did not change during valproic acid therapy. Serum lipid profiles should be carefully monitored in children receiving enzyme inducing antiepileptic drugs.